Purchase Order 75N91020P00820

<p>The National Cancer Institute awarded a purchase order to Advanced Cell Diagnostics, Inc. for laboratory testing with a ceiling value of $19,772.00 and an award date of August 13, 2020. The order carries no set-aside designation and firm fixed pricing. Work is performed in Newark, California. The purchase order has an ultimate completion date of September 30, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Advanced Cell Diagnostics, Inc. for laboratory and testing services valued at $12,345.00, effective August 6, 2020. Performance will take place in Newark, California, with ultimate completion by September 4, 2020. The order carries firm fixed pricing and no set-aside designation.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,696 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. of Newark, California for lab testing services. As the prime contractor, Advanced Cell Diagnostics will provide the requested testing services to the agency. Advanced Cell Diagnostics is a subsidiary of Bio-Techne Corporation, located in Newark. The award does not have a set-aside designation. The contract has a...

Advanced Cell Diagnostics, Inc. has been awarded an $11,183.20 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide RNAscope assay biological products including kits, reagents and probes. As a leader in molecular pathology, Advanced Cell Diagnostics will supply its proprietary RNAScope platform and accompanying products to support the federal research programs of the Department of Health and Human Services agency....

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $16,580 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. for RNAScope under contract number 1187802. Advanced Cell Diagnostics, Inc. will deliver its cell diagnostics technology from its Newark, California location under the eight-month contract ending in March 2024. As part of the National Institutes of Health's medical research efforts, this contract provides RNAScope, a...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,128 purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, for reagents. ACD is a division of Bio-Techne Corporation, doing business as Bio-Techne. The firm fixed price order runs from July 31, 2023 through August 31, 2023 for delivery to ACD's Newark, California facility. No additional details were provided on the original solicitation, major subcontractors, or...

This is a $13,793.20 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company specializing in RNA detection technologies. The contract is for the delivery of 12 custom RNAscope probes and an RNAscope fluorescent reagent kit, which will support various biomedical research efforts across NIAID and...

This firm-fixed-price purchase order was awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Advanced Cell Diagnostics, Inc. (ACD) on September 18, 2020. The $19,999.60 award has an ultimate completion date of September 30, 2021 and does not have a set-aside designation. ACD, a subsidiary of Bio-Techne Corporation, is a molecular diagnostics company that specializes in RNA detection technologies, particularly its proprietary RNAscope platform. The company has...

This firm-fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company specializing in RNA detection technologies. The $20,000.00 contract supports ACD's provision of its proprietary RNAscope reagents, kits, probes, and related services to aid various biomedical research efforts across NIH and its institutes, including the National Cancer Institute, National Institute of...

The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $17,942.50 firm fixed-price purchase order to Advanced Cell Diagnostics, Inc. for services to be performed between August 14, 2023 and December 13, 2023. Advanced Cell Diagnostics, Inc. will deliver the requested products or services as the prime contractor. The parent company of Advanced Cell Diagnostics, Inc. is Bio-Techne Corporation. The place of performance will...